Glenn D. Braunstein | Pathway Genomics

Dr. Braunstein is the former Vice President of Clinical Innovation and Director of the Thyroid Cancer Program at the world-renowned Cedars-Sinai Medical Center. His distinguished career also includes 26 years as Chair of the Department of Medicine at Cedars-Sinai and Vice Chair of the Department of Medicine at the David Geffen School of Medicine at UCLA. At Cedars-Sinai he also held the James R. Klinenberg, M.D. Chair in Medicine and is currently Professor of Medicine there.

Dr. Braunstein has made prominent advances in both reproductive endocrinology and thyroid cancer research and is an active editorial board member for several journals, including American Family Physician, American Journal of Medicine, and Reviews in Endocrinology and Metabolism. Dr. Braunstein also has more than 200 peer-reviewed publications, covering a range of endocrine issues as well as health care delivery models. He has served as chair and Special Advisor on committees at the Food and Drug Administration (FDA) and the American Board of Internal Medicine and was recently named “Top Endocrinologist” by the Los Angeles Business Journal.

Dr. Braunstein earned both his bachelor’s and medical degree from the University of California, San Francisco, followed by an internship and residency at the Harvard University-affiliated Peter Bent Brigham Hospital (now part of Brigham and Women’s Hospital). Dr. Braunstein completed further training in endocrinology at the National Institutes of Health and Harbor General Hospital-UCLA School of Medicine.